Felix von Coerper

Founder at SUNU Ventures BV

Health Technology

Finance

Technology Services

Profile

Felix von Coerper is the founder of SUNU Ventures BV, where he holds the title of Managing Partner starting in 2014.
He is currently a Director at Apic Bio, Inc. since 2019.
Mr. von Coerper previously worked as a Director at Amylyx Pharmaceuticals, Inc.

Felix von Coerper active positions

Companies	Position	Start
SUNU Ventures BV SUNU Ventures BV Investment ManagersFinance SUNU Ventures BV is a venture capital firm founded in 2014 by Von Coerper felix. The firm headquartered at Amsterdam, Netherlands.	Founder	2014-03-31
Apic Bio, Inc. Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA.	Director/Board Member	2019-01-07

All active positions of Felix von Coerper

Former positions of Felix von Coerper

Companies	Position	End
AMYLYX PHARMACEUTICALS, INC.	Director/Board Member	2021-11-30

See the detail of Felix von Coerper's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Felix von Coerper's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AMYLYX PHARMACEUTICALS, INC.	Health Technology

Private companies	2
SUNU Ventures BV SUNU Ventures BV Investment ManagersFinance SUNU Ventures BV is a venture capital firm founded in 2014 by Von Coerper felix. The firm headquartered at Amsterdam, Netherlands.	Finance
Apic Bio, Inc. Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA.	Technology Services